Antonio L. Irigoyen
Toledo, CM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 17, 2019
Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.
Journal: PloS one
Published: November 10, 2017
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.
Journal: International journal of radiation oncology, biology, physics
Published: April 23, 2015
Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.
Journal: BioMed research international
Published: November 04, 2014
Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers.
Journal: Digestive diseases and sciences
Published: May 19, 2014
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 22, 2013
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: December 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026